GRAPE: Graduated Elastic compRession for vAricose Veins in PrEgnancy

Sponsor
Belarusian State Medical University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05122195
Collaborator
(none)
80
2
11
40
3.6

Study Details

Study Description

Brief Summary

This study will be evaluate the clinical efficacy of using graduated compression hosiery for venospecific symptoms, leg edema, and quality of life (QoL) in pregnant women with varicose veins (VV's).

Condition or Disease Intervention/Treatment Phase
  • Other: Compression therapy

Detailed Description

Each pregnant woman randomly receive an envelope. Those who received numbers 01 to 40 constitute the intervention group, and those with numbers 41 to 80 are in the control group.The intervention group will use a thigh length stockings with a compression of 23-32 mmHg, at least 8 hours a day. Verbal and written instructions on the proper use of the stockings will provide. During follow-up period, monitoring the regular use of compression stockings are performed every week. The physical characteristics of the patients, including the age, height, weight, and gestational week, are obtained and recorded. The clinical evaluation are performed using clinical-etiological and anatomical-pathophysiological assessment based on the CEAP classification.

Clinical examinations, QoL assessment and duplex-ultrasound will perform two qualified physicians in the 160 lower limbs of the 80 pregnant women with VV's at three landmark periods: between the 12th and 15th (initial examination), 20th and 28th (intermediate examination), and between the 28th and 36rd (final examination) week of gestation. The study protocol includes examination of the deep and superficial venous system with recording the reflux time and great and small saphenous veins (GSV/SSV) diameters in seven preestablished points, 5 points in the GSV and 2 points in the SSV. A reflux time in the superficial veins above 0.5 s is considered pathological reflux.

The ankle and lower leg circumference are measured using a measuring tape. Measurements are carried out at the lateral and medial ankle and the middle of the lower leg. All measurements are carried out at the same time of the respective days in the late afternoon or early evening; before the measurements the patients underwent a 45-min temperature and cardiovascular equilibrium period in a sitting position.

The QoL and subjective symptoms: tired, heavy legs, sensation of tension, tingling, and pain are assessed at each visit before the volume measurements and ultrasonographic evaluation. The subjective symptoms are evaluated by use of a semiquantitative scale from 0 to 3: 0 = no symptoms; 1 = mild; 2 = moderate; and 3 = severe. The QoL is investigated at each visit by a Chronic Venous Insufficiency Questionnaire (CIVIQ).

Study Design

Study Type:
Observational
Anticipated Enrollment :
80 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Effect of Graduated Elastic compRession Hosiery on vAricose Veins and Leg Edema in PrEgnant Women
Actual Study Start Date :
Jun 1, 2021
Actual Primary Completion Date :
Nov 15, 2021
Anticipated Study Completion Date :
May 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Group A, compression therapy group

Elastic compression therapy with a thigh length stockings of 23-32 mmHg, at least 8 hours a day.

Other: Compression therapy
Graduated elastic compression promote venous flow which is impaired by hormonal changes in the venous system during the gestational period and minimize the blocking effect of the gravid uterus.

Group B, control group

No compression therapy prescribed in the follow-up period.

Outcome Measures

Primary Outcome Measures

  1. Responders to Treatment, Assessed by Duplex Ultrasound [8 weeks]

    Responders; Number of Participants with eliminated superficial pathological reflux between the 20th and 28th weeks of gestation

  2. Responders to Treatment, Assessed by Duplex Ultrasound [16 weeks]

    Responders; Number of Participants with eliminated superficial pathological reflux between the 28th and 36th weeks of gestation

  3. Number of Participants with reduction of the GSV and SSV diameters, Assessed by Duplex Ultrasound [8 weeks]

    Responders; reduction of the GSV and SSV diameters between the 20th and 28th weeks of gestation

  4. Number of Participants with reduction of the GSV and SSV diameters, Assessed by Duplex Ultrasound [16 weeks]

    Responders; Number of Participants with reduction of the GSV and SSV diameters between the 28th and 36th weeks of gestation

  5. Responders to Treatment, Assessed by a measuring tape [8 weeks]

    Responders; Number of Participants with reduction of the ankle and lower leg circumference between the 20th and 28th weeks of gestation

  6. Responders to Treatment, Assessed by a measuring tape [16 weeks]

    Responders; Number of Participants with reduction of the ankle and lower leg circumference between the 28th and 36th weeks of gestation

  7. Number of Participants with pain from absent (score 0) to severe (score 3) [8 weeks]

    None (0), Occasional (1), Daily, intefering with, but not preventing daily activities (2), Daily, limiting most daily activities (3)

  8. Number of Participants with pain from absent (score 0) to severe (score 3) [16 weeks]

    None (0), Occasional (1), Daily, intefering with, but not preventing daily activities (2), Daily, limiting most daily activities (3)

  9. Number of Participants with heavy legs from absent (score 0) to severe (score 3) [8 weeks]

    None (0), Occasional (1), Daily, intefering with, but not preventing daily activities (2), Daily, limiting most daily activities (3)

  10. Number of Participants with heavy legs from absent (score 0) to severe (score 3) [16 weeks]

    None (0), Occasional (1), Daily, intefering with, but not preventing daily activities (2), Daily, limiting most daily activities (3)

  11. Number of Participants with tired legs from absent (score 0) to severe (score 3) [8 weeks]

    None (0), Occasional (1), Daily, intefering with, but not preventing daily activities (2), Daily, limiting most daily activities (3)

  12. Number of Participants with tired legs from absent (score 0) to severe (score 3) [16 weeks]

    None (0), Occasional (1), Daily, intefering with, but not preventing daily activities (2), Daily, limiting most daily activities (3)

  13. Number of Participants with sensation of tension from absent (score 0) to severe (score 3) [8 weeks]

    None (0), Occasional (1), Daily, intefering with, but not preventing daily activities (2), Daily, limiting most daily activities (3)

  14. Number of Participants with sensation of tension from absent (score 0) to severe (score 3) [16 weeks]

    None (0), Occasional (1), Daily, intefering with, but not preventing daily activities (2), Daily, limiting most daily activities (3)

  15. Number of Participants with tingling from absent (score 0) to severe (score 3) [8 weeks]

    None (0), Occasional (1), Daily, intefering with, but not preventing daily activities (2), Daily, limiting most daily activities (3)

  16. Number of Participants with tingling from absent (score 0) to severe (score 3) [16 weeks]

    None (0), Occasional (1), Daily, intefering with, but not preventing daily activities (2), Daily, limiting most daily activities (3)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Pregnant women who are between the 12th and 15th weeks of gestation.

  2. Primary symptomatic varicose veins, Clinical Etiological Anatomical Pathophysiological (CEAP) classification, clinical class C1-C3.

  3. Ability to comprehend and sign an informed consent document.

Exclusion Criteria:
  1. Deep venous thrombosis, thrombophilia associated with a high risk of deep venous thrombosis or postthrombotic syndrome.

  2. Postoperative varicose vein disease recurrence.

  3. History of pulmonary embolism.

  4. Current compression therapy (within 7 days of enrollment).

  5. CEAP clinical class C4-C6.

  6. Arterial occlusive disease and lymphatic pathology of lower limbs.

  7. Edema of limbs other than of venous origin.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Vladimir Khryshchanovich Minsk Minsk Region Belarus 220116
2 Belarusian State Medical University Minsk Belarus 220116

Sponsors and Collaborators

  • Belarusian State Medical University

Investigators

  • Study Chair: Vladimir Khryshchanovich, Educational Institution "Belarusian State Medical University"

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Vladimir Khryshchanovich, Professor, Belarusian State Medical University
ClinicalTrials.gov Identifier:
NCT05122195
Other Study ID Numbers:
  • 20140465
First Posted:
Nov 16, 2021
Last Update Posted:
Nov 24, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Vladimir Khryshchanovich, Professor, Belarusian State Medical University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 24, 2021